Women are also less likely to receive guideline-recommended drug therapy and invasive management of heart disease compared to men, according to U.S. Air Force Col. Travis Batts. This trend forces an elevated focus on pre-pregnancy cardiovascular assessments to lower risks. Heart disease remains the leading cause of death globally for both women and men.